N. Jacobus

发表

Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010-2012 with comparison to 2008-2009.

D. Snydman, Robin Patel, E. Goldstein, 2017, Anaerobe.

A prospective double-blind evaluation of penicillin versus clindamycin in the treatment of odontogenic infections.

S. Gorbach, N. Jacobus, W. Gilmore, 1988, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard M11-A7 2007

W. Gregory, N. Jacobus, D. Hecht, 2012 .

Effect of broad-spectrum parenteral antibiotics on "colonization resistance" of intestinal microflora of humans

S. Gorbach, N. Jacobus, M. Giuliano, 1987, Antimicrobial Agents and Chemotherapy.

Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam

N. Jacobus, P. Petersen, W. Weiss, 1989, Antimicrobial Agents and Chemotherapy.

Contribution of enzymatic properties, cell permeability, and enzyme expression to microbiological activities of beta-lactams in three Bacteroides fragilis isolates that harbor a metallo-beta-lactamase gene

K. Bush, N. Jacobus, B. Rasmussen, 1994, Antimicrobial Agents and Chemotherapy.

Colonization resistance of the human intestinal microflora: Testing the hypothesis in normal volunteers

S. Gorbach, N. Jacobus, M. Giuliano, 1988, European Journal of Clinical Microbiology and Infectious Diseases.

Evaluation of the In Vitro Activity of Eravacycline against a Broad Spectrum of Recent Clinical Anaerobic Isolates

D. Snydman, T. Grossman, N. Jacobus, 2018, Antimicrobial Agents and Chemotherapy.

Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007).

D. Snydman, J. Rosenblatt, V. Yu, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans

S. Gorbach, N. Jacobus, M. Giuliano, 1987, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of Thienamycin

S. Gorbach, N. Jacobus, F. Tally, 1978, Antimicrobial Agents and Chemotherapy.

Glycothiohexides, novel antibiotics produced by "Sebekia" sp. LL-14E605. I. Taxonomy, fermentation and biological evaluation.

C. Pearce, N. Jacobus, D. Montenegro, 1994, The Journal of antibiotics.

Antimicrobial substance from a human Lactobacillus strain

S. Gorbach, N. Jacobus, M. Silva, 1987, Antimicrobial Agents and Chemotherapy.

U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin

D. Snydman, B. A. Forbes, D. Gerding, 2015, Antimicrobial Agents and Chemotherapy.

Susceptibility of the Bacteroides fragilis group in the United States in 1981

S. Gorbach, N. Jacobus, K. Aldridge, 1983, Antimicrobial Agents and Chemotherapy.

Bacteroides fragilis resistance to clindamycin in vitro

S. Gorbach, N. Jacobus, F. Tally, 1982, Antimicrobial Agents and Chemotherapy.

Evaluation of the in vitro activity of NVP-LMB415 against clinical anaerobic isolates with emphasis on the Bacteroides fragilis group.

D. Snydman, N. Jacobus, L. Mcdermott, 2005, The Journal of antimicrobial chemotherapy.

Clindamycin resistance in Bacteroides fragilis.

M. Malamy, N. Jacobus, F. Tally, 1981, The Journal of antimicrobial chemotherapy.

Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria ; Approved Standard — Seventh Edition

S. Jenkins, N. Jacobus, D. Hecht, 2003 .

National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1997-2000.

D. Snydman, R. Venezia, E. Goldstein, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Multicenter Study of In Vitro Susceptibility of theBacteroides fragilis Group, 1995 to 1996, with Comparison of Resistance Trends from 1990 to 1996

D. Snydman, S. Gorbach, S. Jenkins, 1999, Antimicrobial Agents and Chemotherapy.

Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation

N. Jacobus, K. Aldridge, F. Tally, 1988, Antimicrobial Agents and Chemotherapy.

Susceptibility of Anaerobes to Cefoxitin and Other Cephalosporins

J. Bartlett, S. Gorbach, N. Jacobus, 1975, Antimicrobial Agents and Chemotherapy.

TEM-28 from an Escherichia coli clinical isolate is a member of the His-164 family of TEM-1 extended-spectrum beta-lactamases

K. Bush, P. Bradford, N. Jacobus, 1996, Antimicrobial agents and chemotherapy.

In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I

N. Jacobus, P. Petersen, W. Weiss, 1991, Antimicrobial Agents and Chemotherapy.

Synthesis and structure-activity relationships of novel THF 1β-methylcarbapenems

S. Lang, K. Bush, S. Sakya, 1997 .

In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9-t-Butylglycylamido Derivative of Minocycline (GAR-936)

N. Jacobus, P. Petersen, W. Weiss, 1999, Antimicrobial Agents and Chemotherapy.

Pyrroindomycins, novel antibiotics produced by Streptomyces rugosporus LL-42D005. II. Biological activities.

N. Jacobus, P. Petersen, M. P. Singh, 1994, The Journal of antibiotics.

In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines

N. Jacobus, F. Tally, P. Petersen, 1993, Antimicrobial Agents and Chemotherapy.

Comparative In Vitro Activities of Daptomycin and Vancomycin against Resistant Gram-Positive Pathogens

D. Snydman, J. Boyce, N. Jacobus, 2000, Antimicrobial Agents and Chemotherapy.

Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982

S. Gorbach, N. Jacobus, K. Aldridge, 1984, Antimicrobial Agents and Chemotherapy.

A survey of Bacteroides susceptibility in the United States.

S. Gorbach, N. Jacobus, F. Tally, 1981, The Journal of antimicrobial chemotherapy.

Activity of cefmetazole against anaerobic bacteria

S. Gorbach, N. Jacobus, N. Cornick, 1987, Antimicrobial Agents and Chemotherapy.

Activity of Cefamandole and Other Cephalosporins Against Aerobic and Anaerobic Bacteria

N. Jacobus, F. Tally, M. Barza, 1976, Antimicrobial Agents and Chemotherapy.

In-vitro activity of cefoperazone-sulbactam against Bacteroides species.

N. Jacobus, F. Tally, M. B. Souza Dias, 1986, The Journal of antimicrobial chemotherapy.

Cefoxitin inactivation by Bacteroides fragilis

N. Jacobus, F. Tally, G. Cuchural, 1983, Antimicrobial Agents and Chemotherapy.

Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States

S. Gorbach, N. Jacobus, K. Aldridge, 1985, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of Penicillins Against Anaerobes

J. Bartlett, S. Gorbach, N. Jacobus, 1975, Antimicrobial Agents and Chemotherapy.

Activity of cefotetan against anaerobic bacteria.

S. Gorbach, N. Jacobus, F. Tally, 1986, Diagnostic microbiology and infectious disease.

In vitro activity of N-formimidoyl thienamycin (MK0787)

S. Gorbach, N. Jacobus, F. Tally, 1980, Antimicrobial Agents and Chemotherapy.

In vitro activity of LY127935

S. Gorbach, N. Jacobus, F. Tally, 1979, Antimicrobial Agents and Chemotherapy.

In vitro activity of azthreonam, a monobactam antibiotic

N. Jacobus, M. Barza, M. C. Ferreira, 1982, Antimicrobial Agents and Chemotherapy.

In vitro activity of LY146032 against gram-positive bacteria.

S. Gorbach, N. Jacobus, M. Silva, 1988, Diagnostic microbiology and infectious disease.

In Vitro Activities of Aminomethyl-Substituted Analogs of Novel Tetrahydrofuranyl Carbapenems

N. Jacobus, P. Petersen, Yang-i Lin, 1999, Antimicrobial Agents and Chemotherapy.

Synergistic activity of piperacillin: YTR-830H combinations in vitro and in vivo.

N. Jacobus, F. Tally, P. Petersen, 1989, Journal of chemotherapy.

Antimicrobial spectrum of Win 49375

N. Jacobus, F. Tally, M. Barza, 1984, Antimicrobial Agents and Chemotherapy.

Superoxide dismutase in anaerobic bacteria of clinical significance

B. Goldin, S. Gorbach, N. Jacobus, 1977, Infection and immunity.

Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclines.

N. Jacobus, P. Petersen, W. Weiss, 1995, The Journal of antimicrobial chemotherapy.

In Vitro Activities of Tigecycline against the Bacteroides fragilis Group

D. Snydman, R. Ruthazer, N. Jacobus, 2004, Antimicrobial Agents and Chemotherapy.

Susceptibility of anaerobic bacteria to imipenem.

N. Jacobus, F. Tally, 1983, The Journal of antimicrobial chemotherapy.

In vitro activity and serum protein-binding of cefaclor.

N. Jacobus, F. Tally, M. Barza, 1979, The Journal of antimicrobial chemotherapy.

Susceptibility of anaerobes in phase 3 clinical studies of piperacillin/tazobactam.

N. Jacobus, F. Immermann, R. Testa, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In-vitro susceptibility of the Bacteroides fragilis group and the inoculum effect of newer beta-lactam antibiotics on this group of organisms.

N. Jacobus, F. Tally, G. Cuchural, 1989, The Journal of antimicrobial chemotherapy.

The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987.

D. Snydman, N. Jacobus, S. Finegold, 1990, The Journal of antimicrobial chemotherapy.

In Vitro Activities of Newer Quinolones against Bacteroides Group Organisms

D. Snydman, R. Venezia, E. Goldstein, 2002, Antimicrobial Agents and Chemotherapy.

Comparative In Vitro Activities of Clinafloxacin and Trovafloxacin against 1,000 Isolates of Bacteroides fragilisGroup: Effect of the Medium on Test Results

D. Snydman, N. Jacobus, S. Supran, 2000, Antimicrobial Agents and Chemotherapy.

InVitro andInVivoActivities ofLJC10,627, a New Carbapenem withStability toDehydropeptidase I

P. J. Petersen, N. V. Jacobus, W. J. Weiss, 1991 .

Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006-2009.

D. Snydman, J. Rosenblatt, R. Venezia, 2011, Anaerobe.

Mechanistic studies and biological activity of bioxalomycin alpha 2, a novel antibiotic produced by Streptomyces viridodiastaticus subsp. "litoralis" LL-31F508

N. Jacobus, P. Petersen, M. P. Singh, 1994, Antimicrobial Agents and Chemotherapy.

Microbiology and Antibiotic Resistance in Odontogenic Infections

S. Gorbach, N. Jacobus, W. Gilmore, 1991, The Annals of otology, rhinology & laryngology. Supplement.

In Vitro Evaluation of the Activity of Imipenem-Relebactam against 451 Recent Clinical Isolates of Bacteroides Group and Related Species

D. Snydman, N. Jacobus, L. McDermott, 2016, Antimicrobial Agents and Chemotherapy.

National Survey on the Susceptibility of Bacteroides fragilis Group: Report and Analysis of Trends in the United States from 1997 to 2004

N. V. Jacobus, R. Ruthazer, D. Snydman, 2007, Antimicrobial Agents and Chemotherapy.

In Vivo Activities of Peptidic Prodrugs of Novel Aminomethyl Tetrahydrofuranyl-1β-Methylcarbapenems

N. Jacobus, P. Petersen, Yang-i Lin, 1999, Antimicrobial Agents and Chemotherapy.

Comparative efficacy of clindamycin, erythromycin and spiramycin against Staphylococcus aureus in the rat croton oil pouch model.

P. Davey, N. Jacobus, F. Tally, 1987, The Journal of antimicrobial chemotherapy.

In Vitro Susceptibilities of the Bacteroides fragilis Group Species: Change in Isolation Rates Significantly Affects Overall Susceptibility Data

D. Snydman, R. Venezia, E. Goldstein, 2002 .

In Vitro Activity of Ceftaroline against a Broad Spectrum of Recent Clinical Anaerobic Isolates

D. Snydman, N. Jacobus, L. McDermott, 2010, Antimicrobial Agents and Chemotherapy.

Activity of trospectomycin against Bacteroides fragilis and other Bacteroides species

N. Jacobus, F. Tally, 1988, Antimicrobial Agents and Chemotherapy.

In vitro activity of cefbuperazone against Bacteroides spp

S. Gorbach, N. Jacobus, F. Tally, 1985, Antimicrobial Agents and Chemotherapy.

Changes in the antibiotic susceptibility of anaerobic bacteria from 2007-2009 to 2010-2012 based on the CLSI methodology.

Maria Karlsson, Audrey N Schuetz, L. Koeth, 2016, Anaerobe.

Activity of Ceftolozane-Tazobactam against a Broad Spectrum of Recent Clinical Anaerobic Isolates

D. Snydman, N. Jacobus, L. McDermott, 2013, Antimicrobial Agents and Chemotherapy.

Emergence of fluoroquinolone resistance among Bacteroides species.

D. Snydman, R. Venezia, E. Goldstein, 2003, The Journal of antimicrobial chemotherapy.

Susceptibility of anaerobic bacteria to cefoperazone and other beta-lactam antibiotics.

S. Gorbach, N. Jacobus, F. Tally, 1980, Clinical therapeutics.

Peptidic prodrugs of novel aminomethyl-THF 1β-methylcarbapenems

S. Lang, K. Bush, S. Sakya, 1997 .

Mono and bis double ester prodrugs of novel aminomethyl-THF 1β-methylcarbapenems

S. Lang, K. Bush, S. Sakya, 1997 .

Activity of a Novel Cyclic Lipopeptide, CB-183,315, against Resistant Clostridium difficile and Other Gram-Positive Aerobic and Anaerobic Intestinal Pathogens

D. Snydman, N. Jacobus, L. McDermott, 2012, Antimicrobial Agents and Chemotherapy.

Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group

N. Jacobus, F. Tally, S. Finegold, 1990, Antimicrobial Agents and Chemotherapy.

In Vitro Activities of Doripenem, a New Broad-Spectrum Carbapenem, against Recently Collected Clinical Anaerobic Isolates, with Emphasis on the Bacteroides fragilis Group

D. Snydman, N. Jacobus, L. McDermott, 2008, Antimicrobial Agents and Chemotherapy.

Differentiation of Bacteroides ovatus and Bacteroides thetaiotaomicron by means of bacteriophage

N. Jacobus, F. Tally, S. W. Cooper, 1984, Journal of clinical microbiology.

Evaluation of In Vitro Interaction of Daptomycin with Gentamicin or Beta-lactam Antibiotics Against taphylococcus aureus and Enterococci by FIC Index and Timed-Kill Curves

D. Snydman, N. Jacobus, L. McDermott, 2005, Journal of chemotherapy.

In Vitro Evaluation of the Activity of Imipenem-Relebactam against 451 Recent Clinical Isolates of Bacteroides Group and Related Species

D. Snydman, N. Jacobus, L. McDermott, 2016, Antimicrobial Agents and Chemotherapy.